Skip to content
BIO FRONTIER
Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology
GLMD
Home
GLMD
Biotechnology
GLMD
Uncategorized
Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice
Jan 30, 2026
Search for: